G20 Global Health Summit-Indonesia

Pharmaceutical firms are responding to the quick difficulties posed by supply chain disruptions and the need to adapt business procedures in these unprecedented times. If the present COVID-19 pandemic continues for a long time, it may have an influence on the availability of active materials and chemicals (mostly from China), as well as pharmaceutical import and export.